Corporate Member Spotlight: New Phase

New Phase is a MedTech startup from Israel, which is dedicated to transforming the approach to advanced cancer care, particularly in patients with stage IV cancer. By leveraging nanotechnology and electromagnetic systems, New Phase provides a precise, groundbreaking solution to one of the world’s biggest health challenges: cancer. New Phase's mission is to dramatically improve cancer patients' quality of life through innovative and minimally invasive treatments.

New Phase has pioneered the development of a unique treatment system comprising two innovative components: the Sarah Nanoparticle (SaNP) and an Electromagnetic Induction System (EIS) which generates an Alternating Magnetic Field (AMF) and applies electromagnetic hyperthermia, causing destruction to the cancer cells since they are more sensitive to heat, leaving healthy cells unharmed. These components work in tandem to deliver a targeted, non-invasive treatment that destroys cancerous cells while preserving healthy tissue. New Phase's technology is designed to transform cancer from a terminal illness into a manageable condition, improving both patient outcomes and quality of life.

As part of expansion to the U.S., New Phase started its U.S. trial with the Mayo Clinic in Rochester, Minnesota. With more than 30 patients treated in the clinical trials in the U.S. and Israel, promising early results demonstrated either stable disease or destruction of tumors–without any toxic or severe side effects–in patients with stage IV cancer with solid tumors, who had exhausted all other treatments.

New Phase is moving forward to a feasibility multi-center study, with focus on primary liver and ovarian cancer, to show initial efficacy evidence. For this trial, New Phase will soon partner with a leading medical center in Philadelphia. New Phase is currently actively raising $25M Series A, and invites additional investors and funds to join in on the success.

Learn more about New Phase here.

For more information, you can reach out to Irie Meltzer, VP Business Development – iriem@newphase.net